Animal models of fibromyalgia

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  DeSantana, Josimari M ^a   da Cruz, Kamilla M L ^a   Sluka, Kathleen A ^b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ANTISENSE OLIGODEOXYNUCLEOTIDE; BENZODIAZEPINE; BIOGENIC AMINE; CYCLOOXYGENASE 2 INHIBITOR; DELTA OPIATE RECEPTOR AGONIST; DICLOFENAC; DULOXETINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUTAMATE RECEPTOR ANTAGONIST; INTERLEUKIN 6; MILNACIPRAN; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTOXIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; POTASSIUM CHANNEL STIMULATING AGENT; PREGABALIN; PROSTAGLANDIN E2; PROTEIN C FOS; PROTEIN KINASE C EPSILON INHIBITOR; PROTEIN KINASE C INHIBITOR; RESERPINE; SEROTONIN 2C AGONIST; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHLORIDE; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DRUG EFFICACY; FACE VALIDITY; FATIGUE; FIBROMYALGIA; GASTROCNEMIUS MUSCLE; HYPERALGESIA; HYPERSENSITIVITY; MUSCLE DISEASE; MUSCLE FATIGUE; MYALGIA; NEUROPATHIC PAIN; NEUROPATHOLOGY; NOCICEPTION; NONHUMAN; PAIN RECEPTOR; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL DISEASE BY BODY FUNCTION; PRESSORECEPTOR REFLEX; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; STRESS; ANIMAL; DISEASE MODEL;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROMYALGIA;

EID: 84889569256     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4402     Document Type: Review

References (83)

1. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain 2012, 13:715-724. 10.1016/j.jpain.2012.03.009, 22607834.
2. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003, 17:685-701. 10.1016/S1521-6942(03)00035-4, 12849719.
3. Sluka KA. Pain syndromes: myofascial pain and fibromyalgia. Mechanisms and Management of Pain for the Physical Therapist 2009, 279-297. Seattle: IAPS Press, Sluka KA.
4. Dadabhoy D, Crofford LJ, Spaeth M, Russell IJ, Clauw DJ. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 2008, 10:211. 10.1186/ar2443, 2575617, 18768089.
5. Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001, 24:37-46. 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8, 11150964.
6. Miranda A, Peles S, Rudolph C, Shaker R, Sengupta JN. Altered visceral sensation in response to somatic pain in the rat. Gastroenterology 2004, 126:1082-1089. 10.1053/j.gastro.2004.01.003, 15057747.
7. Pratt D, Fuchs PN, Sluka KA. Assessment of avoidance behaviors in mouse models of muscle pain. Neurosci 2013, 248C:54-60.
8. Gandhi R, Ryals JM, Wright DE. Neurotrophin-3 reverses chronic mechanical hyperalgesia induced by intramuscular acid injection. J Neurosci 2004, 24:9405-9413. 10.1523/JNEUROSCI.0899-04.2004, 15496676.
9. Jasper LL, MacNeil BJ. Diverse sensory inputs permit priming in the acidic saline model of hyperalgesia. Eur J Pain 2012, 16:966-973. 10.1002/j.1532-2149.2011.00103.x, 3357443, 22337570.
10. Sluka KA, Price MP, Breese NM, Stucky CL, Wemmie JA, Welsh MJ. Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1. Pain 2003, 106:229-239. 10.1016/S0304-3959(03)00269-0, 14659506.
11. Lin CC, Chen WN, Chen CJ, Lin YW, Zimmer A, Chen CC. An antinociceptive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad Sci U S A 2012, 109:E76-E83. 10.1073/pnas.1108903108, 3258641, 22084095.
12. Oliveira LR, de Melo VU, Macedo FN, Barreto AS, Badaue-Passos D, Viana dos Santos MR, Dias DP, Sluka KA, DeSantana JM, Santana-Filho VJ. Induction of chronic non-inflammatory widespread pain increases cardiac sympathetic modulation in rats. Auton Neurosci 2012, 167:45-49. 10.1016/j.autneu.2011.12.004, 22266357.
13. Sharma NK, Ryals JM, Gajewski BJ, Wright DE. Aerobic exercise alters analgesia and neurotrophin-3 synthesis in an animal model of chronic widespread pain. Phys Ther 2010, 90:714-725. 10.2522/ptj.20090168, 3171655, 20338916.
14. Cheng SJ, Chen CC, Yang HW, Chang YT, Bai SW, Chen CC, Yen CT, Min MY. Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice. J Neurosci 2011, 31:2258-2270. 10.1523/JNEUROSCI.5564-10.2011, 21307262.
15. Chen WK, Liu IY, Chang YT, Chen YC, Chen CC, Yen CT, Shin HS, Chen CC. Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J Neurosci 2010, 30:10360-10368. 10.1523/JNEUROSCI.1041-10.2010, 20685979.
16. Tillu DV, Gebhart GF, Sluka KA. Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult. Pain 2008, 136:331-339. 10.1016/j.pain.2007.07.011, 2519171, 17764841.
17. Radhakrishnan R, Sluka KA. Increased glutamate and decreased glycine release in the rostral ventromedial medulla during induction of a pre-clinical model of chronic widespread muscle pain. Neurosci Lett 2009, 457:141-145. 10.1016/j.neulet.2009.03.086, 2710144, 19429181.
18. da Silva LFS, DeSantana JM, Sluka KA. Activation of NMDA receptors in the brainstem, rostral ventromedial medulla, and nucleus reticularis gigantocellularis mediates mechanical hyperalgesia produced by repeated intramuscular injections of acidic saline in rats. Pain 2010, 11:378-387.
19. da Silva LFS, Walder RY, Davidson BL, Wilson SP, Sluka KA. Changes in expression of NMDA-NR1 receptor subunits in the rostral ventromedial medulla modulates pain behaviors. Pain 2010, 151:155-161. 10.1016/j.pain.2010.06.037, 2943935, 20688433.
20. Skyba DA, King EW, Sluka KA. Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline. Pain 2002, 98:69-78. 10.1016/S0304-3959(01)00471-7, 12098618.
21. Bement MK, Sluka KA. Co-localization of p-CREB and p-NR1 in spinothalamic neurons in a chronic muscle pain model. Neurosci Lett 2007, 418:22-27. 10.1016/j.neulet.2007.02.078, 2689383, 17395373.
22. Skyba DA, Lisi TL, Sluka KA. Excitatory amino acid concentrations increase in the spinal cord dorsal horn after repeated intramuscular injection of acidic saline. Pain 2005, 119:142-149. 10.1016/j.pain.2005.09.025, 16297556.
23. Hoeger-Bement MK, Sluka KA. Phosphorylation of CREB and mechanical hyperalgesia is reversed by blockade of the cAMP pathway in a time-dependent manner after repeated intramuscular acid injections. J Neurosci 2003, 23:5437-5445.
24. Sharma NK, Ryals JM, Liu H, Liu W, Wright DE. Acidic saline-induced primary and secondary mechanical hyperalgesia in mice. J Pain 2009, 10:1231-1241. 10.1016/j.jpain.2009.04.014, 2787877, 19592308.
25. Yokoyama T, Audette KM, Sluka KA. Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. J Pain 2007, 8:422-429. 10.1016/j.jpain.2006.11.007, 17293165.
26. Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM. Chronic muscle pain induced by repeated acid injection is reversed by spinally administered μ-, and δ-, but not κ-, opioid receptor agonists. J Pharmacol Exp Ther 2002, 302:1146-1150. 10.1124/jpet.102.033167, 12183674.
27. Kim SH, Song J, Mun H, Park KU. Effect of the combined use of tramadol and milnacipran on pain threshold in an animal model of fibromyalgia. Korean J Intern Med 2009, 24:139-142. 10.3904/kjim.2009.24.2.139, 2698623, 19543493.
28. Nielsen AN, Mathiesen C, Blackburn-Munro G. Pharmacological characterisation of acid-induced muscle allodynia in rats. Eur J Pharmacol 2004, 487:93-103. 10.1016/j.ejphar.2004.01.017, 15033380.
29. Bement MK, Sluka KA. Low-intensity exercise reverses chronic muscle pain in the rat in a naloxone-dependent manner. Arch Phys Med Rehabil 2005, 86:1736-1740. 10.1016/j.apmr.2005.03.029, 16181935.
30. Sluka KA, O'Donnell JM, Danielson J, Rasmussen LA. Regular physical activity prevents development of chronic pain and activation of central neurons. J Appl Physiol 2013, 114:725-733. 10.1152/japplphysiol.01317.2012, 23271699.
31. Dina OA, Levine JD, Green PG. Muscle inflammation induces a protein kinase C epsilon-dependent chronic-latent muscle pain. J Pain 2008, 9:457-462. 10.1016/j.jpain.2008.01.328, 2424185, 18342576.
32. Parada CA, Reichling DB, Levine JD. Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. Pain 2005, 113:185-190. 10.1016/j.pain.2004.10.021, 15621379.
33. Dina OA, Green PG, Levine JD. Role of interleukin-6 in chronic muscle hyperalgesic priming. Neurosci 2008, 152:521-525.
34. Aley KO, Messing RO, Mochly-Rosen D, Levine JD. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 2000, 20:4680-4685.
35. Ferrari LF, Bogen O, Levine JD. Role of nociceptor alphaCaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats. J Neurosci 2013, 33:11002-11011. 10.1523/JNEUROSCI.1785-13.2013, 23825405.
36. Ferrari LF, Levine E, Levine JD. Role of a novel nociceptor autocrine mechanism in chronic pain. Eur J Neurosci 2013, 37:1705-1713. 10.1111/ejn.12145, 23379641.
37. Joseph EK, Levine JD. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neurosci 2010, 169:431-435.
38. Ferrari LF, Bogen O, Chu C, Levine JD. Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat. J Pain 2013, 14:731-738. 10.1016/j.jpain.2013.01.779, 23664545.
39. Gregory NS, Gibson-Corley K, Frey-Law L, Sluka KA. Fatigue-enhanced hyperalgesia in response to muscle insult: induction and development occur in a sex-dependent manner. Pain 2013,
40. Yokoyama T, Lisi TL, Moore SA, Sluka KA. Muscle fatigue increases the probability of developing hyperalgesia in mice. J Pain 2007, 8:692-699. 10.1016/j.jpain.2007.05.008, 2862310, 17627895.
41. Sluka KA, Rasmussen LA. Fatiguing exercise enhances hyperalgesia to muscle inflammation. Pain 2010, 148:188-197. 10.1016/j.pain.2009.07.001, 2815159, 19632780.
42. Sluka KA, Danielson J, Rasmussen L, Dasilva LF. Exercise-induced pain requires NMDA receptor activation in the medullary raphe nuclei. Med Sci Sports Exerc 2012, 44:420-427. 10.1249/MSS.0b013e31822f490e, 21795998.
43. Nagakura Y, Oe T, Aoki T, Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia. Pain 2009, 146:26-33. 10.1016/j.pain.2009.05.024, 19646816.
44. Nagakura Y, Takahashi M, Noto T, Sekizawa T, Oe T, Yoshimi E, Tamaki K, Shimizu Y. Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Behav Brain Res 2012, 226:242-249. 10.1016/j.bbr.2011.09.023, 21945299.
45. Ogino S, Nagakura Y, Tsukamoto M, Watabiki T, Ozawa T, Oe T, Shimizu Y, Ito H. Systemic administration of 5-HT(2C) receptor agonists attenuates muscular hyperalgesia in reserpine-induced myalgia model. Pharmacol Biochem Behav 2013, 108:8-15.
46. Nishiyori M, Uchida H, Nagai J, Araki K, Mukae T, Kishioka S, Ueda H. Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain 2011, 7:69. 10.1186/1744-8069-7-69, 3184270, 21933442.
47. Nasu T, Taguchi T, Mizumura K. Persistent deep mechanical hyperalgesia induced by repeated cold stress in rats. Eur J Pain 2010, 14:236-244. 10.1016/j.ejpain.2009.05.009, 19560379.
48. Hata T, Itoh E, Kawabata A. Changes in CNS levels of serotonin and its metabolite in SART-stressed (repeatedly cold-stressed) rats. Jpn J Pharmacol 1991, 56:101-104. 10.1254/jjp.56.101, 1715412.
49. Omiya Y, Goto K, Ishige A, Komatsu Y. Changes in analgesia-producing mechanism of repeated cold stress loading in mice. Pharmacol Biochem Behav 2000, 65:261-266. 10.1016/S0091-3057(99)00215-4, 10672978.
50. Fujisawa H, Ohtani-Kaneko R, Naiki M, Okada T, Masuko K, Yudoh K, Suematsu N, Okamoto K, Nishioka K, Kato T. Involvement of post-translational modification of neuronal plasticity-related proteins in hyperalgesia revealed by a proteomic analysis. Proteomics 2008, 8:1706-1719. 10.1002/pmic.200700928, 18340631.
51. Satoh M, Kuraishi Y, Kawamura M. Effects of intrathecal antibodies to substance-P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia - comparison with carrageenan-induced hyperalgesia. Pain 1992, 49:273-278. 10.1016/0304-3959(92)90151-Z, 1376888.
52. Kuraishi Y, Satoh M. Participation of spinal cord substance P in hyperalgesia induced by repeated cold stress. Regul Pept 1993, 46:405-406. 10.1016/0167-0115(93)90101-D, 7692549.
53. Okano K, Kuraishi Y, Satoh M. Effects of intrathecally injected glutamate and substance P antagonists on repeated cold stress-induced hyperalgesia in rats. Biol Pharm Bull 1995, 18:42-44. 10.1248/bpb.18.42, 7537576.
54. Nishiyori M, Ueda H. Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain 2008, 4:52. 10.1186/1744-8069-4-52, 2596100, 18990235.
55. Khasar SG, Dina OA, Green PG, Levine JD. Sound stress-induced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines. J Pain 2009, 10:1073-1077. 10.1016/j.jpain.2009.04.005, 2757466, 19576859.
56. Dina OA, Levine JD, Green PG. Enhanced cytokine-induced mechanical hyperalgesia in skeletal muscle produced by a novel mechanism in rats exposed to unpredictable sound stress. Eur J Pain 2011, 15:796-800. 10.1016/j.ejpain.2011.02.005, 3123688, 21419675.
57. Green PG, Alvarez P, Gear RW, Mendoza D, Levine JD. Further validation of a model of fibromyalgia syndrome in the rat. J Pain 2011, 12:811-818. 10.1016/j.jpain.2011.01.006, 3130888, 21481648.
58. Khasar SG, Burkham J, Dina OA, Brown AS, Bogen O, Alessandri-Haber N, Green PG, Reichling DB, Levine JD. Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain. J Neurosci 2008, 28:5721-5730. 10.1523/JNEUROSCI.0256-08.2008, 2518401, 18509033.
59. Quintero L, Moreno M, Avila C, Arcaya J, Maixner W, Suarez-Roca H. Long-lasting delayed hyperalgesia after subchronic swim stress. Pharmacol Biochem Behav 2000, 67:449-458. 10.1016/S0091-3057(00)00374-9, 11164071.
60. Quintero L, Cuesta MC, Silva JA, Arcaya JL, Pinerua-Suhaibar L, Maixner W, Suarez-Roca H. Repeated swim stress increases pain-induced expression of c-Fos in the rat lumbar cord. Brain Res 2003, 965:259-268. 10.1016/S0006-8993(02)04224-5, 12591144.
61. Suarez-Roca H, Quintero L, Arcaya JL, Maixner W, Rao SG. Stress-induced muscle and cutaneous hyperalgesia: differential effect of milnacipran. Physiol Behav 2006, 88:82-87. 10.1016/j.physbeh.2006.03.010, 16624346.
62. Suarez-Roca H, Leal L, Silva JA, Pinerua-Shuhaibar L, Quintero L. Reduced GABA neurotransmission underlies hyperalgesia induced by repeated forced swimming stress. Behav Brain Res 2008, 189:159-169. 10.1016/j.bbr.2007.12.022, 18255166.
63. Quintero L, Cardenas R, Suarez-Roca H. Stress-induced hyperalgesia is associated with a reduced and delayed GABA inhibitory control that enhances post-synaptic NMDA receptor activation in the spinal cord. Pain 2011, 152:1909-1922. 10.1016/j.pain.2011.04.017, 21636214.
64. Frey Law LA, Sluka KA, McMullen T, Lee J, rendt-Nielsen L, Graven-Nielsen T. Acidic buffer induced muscle pain evokes referred pain and mechanical hyperalgesia in humans. Pain 2008, 140:254-264. 10.1016/j.pain.2008.08.014, 2613646, 18835099.
65. Issberner U, Reeh PW, Steen KH. Pain due to tissue acidosis: a mechanism for inflammatory and ischemic myalgia?. Neurosci Lett 1996, 208:191-194. 10.1016/0304-3940(96)12576-3, 8733302.
66. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333-1343. 10.1002/art.10225, 12115241.
67. Gautam M, Benson CJ, Ranier JD, Light AR, Sluka KA. ASICs do not play a role in maintaining hyperalgesia induced by repeated intramuscular acid injections. Pain Res Treat 2012, 2012:817347. 3236358, 22191025.
68. Karczewski J, Spencer RH, Garsky VM, Liang A, Leitl MD, Cato MJ, Cook SP, Kane S, Urban MO. Reversal of acid-induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2. Br J Pharmacol 2010, 161:950-960. 10.1111/j.1476-5381.2010.00918.x, 2992907, 20860671.
69. Sluka KA, Audette KM. Activation of protein kinase C in the spinal cord produces mechanical hyperalgesia by activating glutamate receptors, but does not mediate chronic muscle-induced hyperalgesia. Mol Pain 2006, 2:13. 10.1186/1744-8069-2-13, 1482680, 16584564.
70. Miranda A, Peles S, McLean PG, Sengupta JN. Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia. Pain 2006, 126:54-63. 10.1016/j.pain.2006.06.014, 16844296.
71. Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2007, CD003786.
72. Sluka KA, O'Donnell JM, Danielson J, Rasmussen LA. Regular physical activity prevents development of chronic pain and activation of central neurons. J Appl Physiol 2012, 114:725-733.
73. Ellingson LD, Shields MR, Stegner AJ, Cook DB. Physical activity, sustained sedentary behavior, and pain modulation in women with fibromyalgia. J Pain 2012, 13:195-206. 10.1016/j.jpain.2011.11.001, 3272134, 22245361.
74. Landmark T, Romundstad P, Borchgrevink PC, Kaasa S, Dale O. Associations between recreational exercise and chronic pain in the general population: evidence from the HUNT 3 study. Pain 2011, 152:2241-2247. 10.1016/j.pain.2011.04.029, 21601986.
75. Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol 2013, 19:72-77. 10.1097/RHU.0b013e3182863447, 23364665.
76. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998, 18:13-19.
77. Light AR, White AT, Hughen RW, Light KC. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain 2009, 10:1099-1112. 10.1016/j.jpain.2009.06.003, 2757484, 19647494.
78. Yunus MB, Masi AT, Aldag JC. Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol 1989, 16:527-532.
79. Arnold LM. The pathophysiology, diagnosis and treatment of fibromyalgia. Psychiatr Clin North Am 2010, 33:375-408. 10.1016/j.psc.2010.01.001, 20385343.
80. Nishiyori M, Nagai J, Nakazawa T, Ueda H. Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia. Neurosci Lett 2010, 472:184-187. 10.1016/j.neulet.2010.01.080, 20138970.
81. Bardin L, Malfetes N, Newman-Tancredi A, Depoortere R. Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: relevance to human stress-associated painful pathologies. Behav Brain Res 2009, 205:360-366. 10.1016/j.bbr.2009.07.005, 19616033.
82. Bardin L, Gregoire S, Aliaga M, Malfetes N, Vitton O, Ladure P, Newman-Tancredi A, Depoortere R. Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats. Neurosci Res 2010, 66:135-140. 10.1016/j.neures.2009.10.009, 19883699.
83. Gregory NS, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA. An overview of animal models of pain: disease models and outcome measures. J Pain 2013, 14:1255-1269. 10.1016/j.jpain.2013.06.008, 24035349.